Mapping knowledge landscapes and emerging trends in artificial intelligence for antimicrobial resistance: bibliometric and visualization analysis
To systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in t...
Saved in:
Published in | Frontiers in medicine Vol. 12; p. 1492709 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in this dynamic field.
A comprehensive bibliometric analysis was performed using the Web of Science Core Collection database for publications from 2014 to 2024. The analysis integrated multiple bibliometric approaches: VOSviewer for visualization of collaboration networks and research clusters, CiteSpace for temporal evolution analysis, and quantitative analysis of publication metrics. Key bibliometric indicators including co-authorship patterns, keyword co-occurrence, and citation impact were analyzed to delineate research evolution and collaboration patterns in this domain.
A collection of 2,408 publications was analyzed, demonstrating significant annual growth with publications increasing from 4 in 2014 to 549 in 2023 (22.7% of total output). The United States (707), China (581), and India (233) were the leading contributors in international collaborations. The Chinese Academy of Sciences (53), Harvard Medical School (43), and University of California San Diego (26) were identified as top contributing institutions. Citation analysis highlighted two major breakthroughs: AlphaFold's protein structure prediction (6,811 citations) and deep learning approaches to antibiotic discovery (4,784 citations). Keyword analysis identified six enduring research clusters from 2014 to 2024: sepsis, artificial neural networks, antimicrobial resistance, antimicrobial peptides, drug repurposing, and molecular docking, demonstrating the sustained integration of AI in antimicrobial therapy development. Recent trends show increasing application of AI technologies in traditional approaches, particularly in MALDI-TOF MS for pathogen identification and graph neural networks for large-scale molecular screening.
This bibliometric analysis shows the importance of artificial intelligence in enhancing the progress in the discovery of antimicrobial drugs especially toward the fight against AMR. From enhancing the fast, efficient and predictive performance of drug discovery methods, current AI capabilities have revealed observable potential to be proactive in combating the ever-growing challenge of AMR worldwide. This study serves not only an identification of current trends, but also, and especially, offers a strategic approach to further investigations. |
---|---|
AbstractList | To systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in this dynamic field.ObjectiveTo systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in this dynamic field.A comprehensive bibliometric analysis was performed using the Web of Science Core Collection database for publications from 2014 to 2024. The analysis integrated multiple bibliometric approaches: VOSviewer for visualization of collaboration networks and research clusters, CiteSpace for temporal evolution analysis, and quantitative analysis of publication metrics. Key bibliometric indicators including co-authorship patterns, keyword co-occurrence, and citation impact were analyzed to delineate research evolution and collaboration patterns in this domain.MethodsA comprehensive bibliometric analysis was performed using the Web of Science Core Collection database for publications from 2014 to 2024. The analysis integrated multiple bibliometric approaches: VOSviewer for visualization of collaboration networks and research clusters, CiteSpace for temporal evolution analysis, and quantitative analysis of publication metrics. Key bibliometric indicators including co-authorship patterns, keyword co-occurrence, and citation impact were analyzed to delineate research evolution and collaboration patterns in this domain.A collection of 2,408 publications was analyzed, demonstrating significant annual growth with publications increasing from 4 in 2014 to 549 in 2023 (22.7% of total output). The United States (707), China (581), and India (233) were the leading contributors in international collaborations. The Chinese Academy of Sciences (53), Harvard Medical School (43), and University of California San Diego (26) were identified as top contributing institutions. Citation analysis highlighted two major breakthroughs: AlphaFold's protein structure prediction (6,811 citations) and deep learning approaches to antibiotic discovery (4,784 citations). Keyword analysis identified six enduring research clusters from 2014 to 2024: sepsis, artificial neural networks, antimicrobial resistance, antimicrobial peptides, drug repurposing, and molecular docking, demonstrating the sustained integration of AI in antimicrobial therapy development. Recent trends show increasing application of AI technologies in traditional approaches, particularly in MALDI-TOF MS for pathogen identification and graph neural networks for large-scale molecular screening.ResultsA collection of 2,408 publications was analyzed, demonstrating significant annual growth with publications increasing from 4 in 2014 to 549 in 2023 (22.7% of total output). The United States (707), China (581), and India (233) were the leading contributors in international collaborations. The Chinese Academy of Sciences (53), Harvard Medical School (43), and University of California San Diego (26) were identified as top contributing institutions. Citation analysis highlighted two major breakthroughs: AlphaFold's protein structure prediction (6,811 citations) and deep learning approaches to antibiotic discovery (4,784 citations). Keyword analysis identified six enduring research clusters from 2014 to 2024: sepsis, artificial neural networks, antimicrobial resistance, antimicrobial peptides, drug repurposing, and molecular docking, demonstrating the sustained integration of AI in antimicrobial therapy development. Recent trends show increasing application of AI technologies in traditional approaches, particularly in MALDI-TOF MS for pathogen identification and graph neural networks for large-scale molecular screening.This bibliometric analysis shows the importance of artificial intelligence in enhancing the progress in the discovery of antimicrobial drugs especially toward the fight against AMR. From enhancing the fast, efficient and predictive performance of drug discovery methods, current AI capabilities have revealed observable potential to be proactive in combating the ever-growing challenge of AMR worldwide. This study serves not only an identification of current trends, but also, and especially, offers a strategic approach to further investigations.ConclusionThis bibliometric analysis shows the importance of artificial intelligence in enhancing the progress in the discovery of antimicrobial drugs especially toward the fight against AMR. From enhancing the fast, efficient and predictive performance of drug discovery methods, current AI capabilities have revealed observable potential to be proactive in combating the ever-growing challenge of AMR worldwide. This study serves not only an identification of current trends, but also, and especially, offers a strategic approach to further investigations. To systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in this dynamic field. A comprehensive bibliometric analysis was performed using the Web of Science Core Collection database for publications from 2014 to 2024. The analysis integrated multiple bibliometric approaches: VOSviewer for visualization of collaboration networks and research clusters, CiteSpace for temporal evolution analysis, and quantitative analysis of publication metrics. Key bibliometric indicators including co-authorship patterns, keyword co-occurrence, and citation impact were analyzed to delineate research evolution and collaboration patterns in this domain. A collection of 2,408 publications was analyzed, demonstrating significant annual growth with publications increasing from 4 in 2014 to 549 in 2023 (22.7% of total output). The United States (707), China (581), and India (233) were the leading contributors in international collaborations. The Chinese Academy of Sciences (53), Harvard Medical School (43), and University of California San Diego (26) were identified as top contributing institutions. Citation analysis highlighted two major breakthroughs: AlphaFold's protein structure prediction (6,811 citations) and deep learning approaches to antibiotic discovery (4,784 citations). Keyword analysis identified six enduring research clusters from 2014 to 2024: sepsis, artificial neural networks, antimicrobial resistance, antimicrobial peptides, drug repurposing, and molecular docking, demonstrating the sustained integration of AI in antimicrobial therapy development. Recent trends show increasing application of AI technologies in traditional approaches, particularly in MALDI-TOF MS for pathogen identification and graph neural networks for large-scale molecular screening. This bibliometric analysis shows the importance of artificial intelligence in enhancing the progress in the discovery of antimicrobial drugs especially toward the fight against AMR. From enhancing the fast, efficient and predictive performance of drug discovery methods, current AI capabilities have revealed observable potential to be proactive in combating the ever-growing challenge of AMR worldwide. This study serves not only an identification of current trends, but also, and especially, offers a strategic approach to further investigations. ObjectiveTo systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research through bibliometric analysis, providing evidence-based insights to guide future research directions and inform strategic decision-making in this dynamic field.MethodsA comprehensive bibliometric analysis was performed using the Web of Science Core Collection database for publications from 2014 to 2024. The analysis integrated multiple bibliometric approaches: VOSviewer for visualization of collaboration networks and research clusters, CiteSpace for temporal evolution analysis, and quantitative analysis of publication metrics. Key bibliometric indicators including co-authorship patterns, keyword co-occurrence, and citation impact were analyzed to delineate research evolution and collaboration patterns in this domain.ResultsA collection of 2,408 publications was analyzed, demonstrating significant annual growth with publications increasing from 4 in 2014 to 549 in 2023 (22.7% of total output). The United States (707), China (581), and India (233) were the leading contributors in international collaborations. The Chinese Academy of Sciences (53), Harvard Medical School (43), and University of California San Diego (26) were identified as top contributing institutions. Citation analysis highlighted two major breakthroughs: AlphaFold’s protein structure prediction (6,811 citations) and deep learning approaches to antibiotic discovery (4,784 citations). Keyword analysis identified six enduring research clusters from 2014 to 2024: sepsis, artificial neural networks, antimicrobial resistance, antimicrobial peptides, drug repurposing, and molecular docking, demonstrating the sustained integration of AI in antimicrobial therapy development. Recent trends show increasing application of AI technologies in traditional approaches, particularly in MALDI-TOF MS for pathogen identification and graph neural networks for large-scale molecular screening.ConclusionThis bibliometric analysis shows the importance of artificial intelligence in enhancing the progress in the discovery of antimicrobial drugs especially toward the fight against AMR. From enhancing the fast, efficient and predictive performance of drug discovery methods, current AI capabilities have revealed observable potential to be proactive in combating the ever-growing challenge of AMR worldwide. This study serves not only an identification of current trends, but also, and especially, offers a strategic approach to further investigations. |
Author | Wang, Zhongli Li, Shixue Zhu, Gaopei |
AuthorAffiliation | 3 Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University , Jinan , China 2 NHC Key Lab of Health Economics and Policy Research, Shandong University , Jinan , China 1 Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University , Jinan , China |
AuthorAffiliation_xml | – name: 3 Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University , Jinan , China – name: 1 Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University , Jinan , China – name: 2 NHC Key Lab of Health Economics and Policy Research, Shandong University , Jinan , China |
Author_xml | – sequence: 1 givenname: Zhongli surname: Wang fullname: Wang, Zhongli – sequence: 2 givenname: Gaopei surname: Zhu fullname: Zhu, Gaopei – sequence: 3 givenname: Shixue surname: Li fullname: Li, Shixue |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39935800$$D View this record in MEDLINE/PubMed |
BookMark | eNpVks1u1TAQhSNUREvpA7BBWbK5F_8mMRuEKn4qFbEBiZ01dibBxbGDnduqvAVvjNN7qdqVxz7H38ie87w6CjFgVb2kZMt5p94ME_ZbRpjcUqFYS9ST6oQx1Ww62f04elAfV2c5XxFCKGdSUP6sOuZKcdkRclL9_QLz7MJY_wrxxmM_Yu0h9NnCjLkuVY0TpnF1LAmLULtQQ1rc4KwDX3YLeu9GDBbrIaZyZXGTsymaVU6YXV6giG9r44x3ccIlOXtHvnZ5B979gcXFAg3gb4v7RfV0AJ_x7LCeVt8_fvh2_nlz-fXTxfn7y40VtFs2vRFIhEFoGta2QNiAXLVguKCSEzooKxmVCITaYmhUMxDDeUOGnrBeScFPq4s9t49wpefkJki3OoLTdwcxjXp9p_WoUXEjwSrR9iAME4pag6IzhhFrVMcL692eNe9MGYvFsCTwj6CPleB-6jFea0o7SlqxEl4fCCn-3mFe9OSyLV8LAeMua04b2UmhOlKsrx42u-_yf6jFQPeGMoWcEw73Fkr0mh29Zkev2dGH7PB_TxS79g |
Cites_doi | 10.1038/s41598-022-10563-8 10.3390/s23198132 10.1093/nar/gkz935 10.1038/s41573-023-00774-7 10.1038/s41591-018-0300-7 10.1002/asi.21525 10.1016/j.bios.2023.115941 10.3390/antibiotics10081005 10.1038/s41591-021-01614-0 10.3390/diagnostics12020413 10.1038/s41586-023-06221-2 10.1016/j.tcb.2022.11.011 10.2196/42185 10.1128/msystems.00789-24 10.3390/antibiotics9120918 10.3390/ijms20235844 10.1016/j.drudis.2021.06.009 10.1007/978-981-15-8002-4_13 10.1109/TNNLS.2020.2978386 10.1073/pnas.1803294115 10.3390/antibiotics12111594 10.3390/antibiotics9110767 10.1038/d41586-018-02174-z 10.1038/nrd.2018.168 10.15252/emmm.201910264 10.1016/j.compbiomed.2023.107496 10.1038/s41598-023-50832-8 10.1371/journal.pmed.1004264 10.26355/eurrev_202401_34886 10.5555/20173071720 10.1016/j.avsg.2022.03.019 10.1021/acs.jcim.3c00516 10.1038/s41586-023-06887-8 10.1016/j.chemosphere.2023.139064 10.1186/s40168-018-0401-z 10.1002/pro.5006 10.3390/microorganisms10061239 10.1016/S0140-6736(21)02724-0 10.1016/j.ijantimicag.2022.106684 10.3389/fmicb.2019.00539 10.1016/j.scitotenv.2013.01.032 10.1007/s11192-009-0146-3 10.1002/asi.20317 10.1016/j.drudis.2022.103410 10.1016/j.ijbiomac.2024.129848 10.3389/fphar.2020.00842 10.1016/j.cell.2020.04.001 10.1007/s11030-021-10217-3 10.1186/s13756-019-0493-7 10.1016/j.engappai.2019.06.010 10.1038/s42256-022-00465-9 10.1126/science.1155157 10.4103/ijd.IJD_421_20 10.1016/j.neunet.2014.09.003 10.1038/s41586-021-03819-2 10.1016/j.ijfoodmicro.2022.109862 10.1016/j.drudis.2023.103491 10.1128/cmr.00179-21 |
ContentType | Journal Article |
Copyright | Copyright © 2025 Wang, Zhu and Li. Copyright © 2025 Wang, Zhu and Li. 2025 Wang, Zhu and Li |
Copyright_xml | – notice: Copyright © 2025 Wang, Zhu and Li. – notice: Copyright © 2025 Wang, Zhu and Li. 2025 Wang, Zhu and Li |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fmed.2025.1492709 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2296-858X |
ExternalDocumentID | oai_doaj_org_article_e93b5ac947da4b2491cbe48bb20cb983 PMC11810743 39935800 10_3389_fmed_2025_1492709 |
Genre | Systematic Review Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK GROUPED_DOAJ HYE KQ8 M48 M~E OK1 PGMZT RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c418t-db4e04bea66277a02fe397ab3415301f9c5215ea01c627696f0b3360fd02d9543 |
IEDL.DBID | M48 |
ISSN | 2296-858X |
IngestDate | Wed Aug 27 01:28:45 EDT 2025 Thu Aug 21 18:28:27 EDT 2025 Fri Jul 11 02:01:14 EDT 2025 Thu Apr 03 07:00:44 EDT 2025 Tue Jul 01 00:45:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | deep learning antimicrobial resistance antibiotics bibliometric analysis artificial intelligence |
Language | English |
License | Copyright © 2025 Wang, Zhu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c418t-db4e04bea66277a02fe397ab3415301f9c5215ea01c627696f0b3360fd02d9543 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Reviewed by: Reham M. El-Tarabili, Suez Canal University, Egypt Tong Wu, University of Massachusetts Lowell, United States Edited by: Shisan (Bob) Bao, The University of Sydney, Australia |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fmed.2025.1492709 |
PMID | 39935800 |
PQID | 3165854980 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e93b5ac947da4b2491cbe48bb20cb983 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11810743 proquest_miscellaneous_3165854980 pubmed_primary_39935800 crossref_primary_10_3389_fmed_2025_1492709 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-00-00 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – year: 2025 text: 2025-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in medicine |
PublicationTitleAlternate | Front Med (Lausanne) |
PublicationYear | 2025 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Teodoro (ref54) 2022; 379 Basu (ref14) 2020; 65 Jumper (ref25) 2021; 596 Liu (ref27) 2021; 26 Ke (ref22) 2020; 11 Rajpurkar (ref17) 2022; 28 Topol (ref8) 2019; 25 Kim (ref42) 2022; 35 Dantas (ref1) 2008; 320 Mulani (ref57) 2019; 10 Fanelli (ref3) 2020; 9 (ref39) 2017 Urbina (ref31) 2023; 28 Alcock (ref34) 2020; 48 Talat (ref12) 2023; 28 Kleandrova (ref47) 2021; 10 O’Neill (ref2) 2016; 84 Shukla (ref18) 2019; 85 Annunziato (ref6) 2019; 20 Walsh (ref4) 2023; 20 Chen (ref24) 2006; 57 Charani (ref7) 2019; 8 Wong (ref13) 2024; 626 Tang (ref19) 2022; 24 Khaledi (ref37) 2020; 12 Gupta (ref49) 2021; 25 Abu-Aqil (ref33) 2023; 23 Kong (ref28) 2019; 11 Stokes (ref26) 2020; 181 Palazzotti (ref51) 2023; 63 Arango-Argoty (ref36) 2018; 6 Nguyen (ref52) 2024; 9 Kuppuswamy (ref29) 2021 Tarín-Pelló (ref48) 2023; 166 Gheytanzadeh (ref59) 2022; 12 Mullowney (ref9) 2023; 22 (ref38) 2022; 399 Yao (ref56) 2024; 33 Wang (ref10) 2023; 620 Zhongguan (ref58) 2023; 337 Wesołowska (ref53) 2023; 12 Krentzel (ref11) 2023; 33 Javidan (ref21) 2022; 85 Van Eck (ref23) 2010; 84 Wang (ref60) 2024; 248 Rizzo (ref41) 2013; 447 Das (ref50) 2024; 261 Yue (ref55) 2024; 14 Schmidhuber (ref45) 2015; 61 Wu (ref35) 2020; 32 Webb (ref16) 2018; 554 Cobo (ref15) 2011; 62 Qi (ref20) 2024; 28 Sionov (ref5) 2022; 10 Wang (ref32) 2022; 12 Urbina (ref30) 2022; 4 Ryu (ref44) 2018; 115 Tiseo (ref40) 2020; 9 Tang (ref43) 2022; 60 Pushpakom (ref46) 2019; 18 |
References_xml | – volume: 12 start-page: 6615 year: 2022 ident: ref59 article-title: An insight into tetracycline photocatalytic degradation by MOFs using the artificial intelligence technique publication-title: Sci Rep doi: 10.1038/s41598-022-10563-8 – volume: 23 start-page: 8132 year: 2023 ident: ref33 article-title: Quick detection of Proteus and Pseudomonas in Patients' urine and assessing their antibiotic susceptibility using infrared spectroscopy and machine learning publication-title: Sensors doi: 10.3390/s23198132 – volume: 48 start-page: D517 year: 2020 ident: ref34 article-title: CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database publication-title: Nucleic Acids Res doi: 10.1093/nar/gkz935 – volume: 22 start-page: 895 year: 2023 ident: ref9 article-title: Artificial intelligence for natural product drug discovery publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-023-00774-7 – volume: 25 start-page: 44 year: 2019 ident: ref8 article-title: High-performance medicine: the convergence of human and artificial intelligence publication-title: Nat Med doi: 10.1038/s41591-018-0300-7 – volume: 62 start-page: 1382 year: 2011 ident: ref15 article-title: Science mapping software tools: review, analysis, and cooperative study among tools publication-title: J Am Soc Inf Sci Technol doi: 10.1002/asi.21525 – volume: 248 start-page: 115941 year: 2024 ident: ref60 article-title: Sulfur vacancy defects mediated CdZnTeS@BC heterojunction: artificial intelligence-assisted self-enhanced electrochemiluminescence molecularly imprinted sensing of CTC publication-title: Biosens Bioelectron doi: 10.1016/j.bios.2023.115941 – volume: 10 start-page: 1005 year: 2021 ident: ref47 article-title: Computational drug repurposing for Antituberculosis therapy: discovery of multi-strain inhibitors publication-title: Antibiotics-Basel doi: 10.3390/antibiotics10081005 – volume: 28 start-page: 31 year: 2022 ident: ref17 article-title: AI in health and medicine publication-title: Nat Med doi: 10.1038/s41591-021-01614-0 – volume: 12 start-page: 413 year: 2022 ident: ref32 article-title: Investigating unfavorable factors that impede MALDI-TOF-based AI in predicting antibiotic resistance publication-title: Diagnostics (Basel) doi: 10.3390/diagnostics12020413 – volume: 620 start-page: 47 year: 2023 ident: ref10 article-title: Scientific discovery in the age of artificial intelligence publication-title: Nature doi: 10.1038/s41586-023-06221-2 – volume: 33 start-page: 538 year: 2023 ident: ref11 article-title: Deep learning in image-based phenotypic drug discovery publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2022.11.011 – volume: 24 start-page: e42185 year: 2022 ident: ref19 article-title: Artificial intelligence in intensive care medicine: Bibliometric analysis publication-title: J Med Internet Res doi: 10.2196/42185 – volume: 9 start-page: e0078924 year: 2024 ident: ref52 article-title: Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra publication-title: mSystems doi: 10.1128/msystems.00789-24 – volume: 9 start-page: 918 year: 2020 ident: ref40 article-title: Global trends in antimicrobial use in food animals from 2017 to 2030 publication-title: Antibiotics-Basel doi: 10.3390/antibiotics9120918 – volume: 20 start-page: 5844 year: 2019 ident: ref6 article-title: Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review publication-title: Int J Mol Sci doi: 10.3390/ijms20235844 – year: 2017 ident: ref39 – volume: 26 start-page: 2593 year: 2021 ident: ref27 article-title: AI-based language models powering drug discovery and development publication-title: Drug Discov Today doi: 10.1016/j.drudis.2021.06.009 – start-page: 303 volume-title: Drug Discovery and Drug Development: The Indian Narrative year: 2021 ident: ref29 article-title: New drug discovery and development: Indian pharmaceutical industry doi: 10.1007/978-981-15-8002-4_13 – volume: 11 start-page: 2632 year: 2019 ident: ref28 article-title: Artificial intelligence: a key to relieve China’s insufficient and unequally-distributed medical resources publication-title: Am J Transl Res – volume: 32 start-page: 4 year: 2020 ident: ref35 article-title: A comprehensive survey on graph neural networks publication-title: IEEE T Neur Net Learn doi: 10.1109/TNNLS.2020.2978386 – volume: 115 start-page: E4304 year: 2018 ident: ref44 article-title: Deep learning improves prediction of drug–drug and drug–food interactions publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1803294115 – volume: 12 start-page: 1594 year: 2023 ident: ref53 article-title: Occurrence and antimicrobial resistance among staphylococci isolated from the skin microbiota of healthy goats and sheep publication-title: Antibiotics-Basel doi: 10.3390/antibiotics12111594 – volume: 9 start-page: 767 year: 2020 ident: ref3 article-title: Role of artificial intelligence in fighting antimicrobial resistance in pediatrics publication-title: Antibiotics Basel doi: 10.3390/antibiotics9110767 – volume: 554 start-page: 555 year: 2018 ident: ref16 article-title: Deep learning for biology publication-title: Nature doi: 10.1038/d41586-018-02174-z – volume: 18 start-page: 41 year: 2019 ident: ref46 article-title: Drug repurposing: progress, challenges and recommendations publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2018.168 – volume: 12 start-page: e10264 year: 2020 ident: ref37 article-title: Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics publication-title: EMBO Mol Med doi: 10.15252/emmm.201910264 – volume: 166 start-page: 107496 year: 2023 ident: ref48 article-title: Computer-aided drug repurposing to tackle antibiotic resistance based on topological data analysis publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2023.107496 – volume: 14 start-page: 947 year: 2024 ident: ref55 article-title: Machine learning assisted rational design of antimicrobial peptides based on human endogenous proteins and their applications for cosmetic preservative system optimization publication-title: Sci Rep doi: 10.1038/s41598-023-50832-8 – volume: 20 start-page: e1004264 year: 2023 ident: ref4 article-title: Antimicrobial resistance: addressing a global threat to humanity publication-title: PLoS Med doi: 10.1371/journal.pmed.1004264 – volume: 28 start-page: 1 year: 2024 ident: ref20 article-title: Global trends in coronary artery disease and artificial intelligence relevant studies: a bibliometric analysis publication-title: Eur Rev Med Pharmaco doi: 10.26355/eurrev_202401_34886 – volume: 84 start-page: 1720 year: 2016 ident: ref2 article-title: Tackling drug-resistant infections globally: final report and recommendations publication-title: Rev. Antimicrob. Resist. doi: 10.5555/20173071720 – volume: 85 start-page: 395 year: 2022 ident: ref21 article-title: A systematic review and bibliometric analysis of applications of artificial intelligence and machine learning in vascular surgery publication-title: Ann Vasc Surg doi: 10.1016/j.avsg.2022.03.019 – volume: 63 start-page: 4875 year: 2023 ident: ref51 article-title: Fighting antimicrobial resistance: insights on how the Staphylococcus aureus NorA efflux pump recognizes 2-Phenylquinoline inhibitors by supervised molecular dynamics (SuMD) and molecular docking simulations publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.3c00516 – volume: 626 start-page: 177 year: 2024 ident: ref13 article-title: Discovery of a structural class of antibiotics with explainable deep learning publication-title: Nature doi: 10.1038/s41586-023-06887-8 – volume: 337 start-page: 139064 year: 2023 ident: ref58 article-title: Cost-effective one-spot hydrothermal synthesis of graphene oxide nanoparticles for wastewater remediation: AI-enhanced approach for transition metal oxides publication-title: Chemosphere doi: 10.1016/j.chemosphere.2023.139064 – volume: 6 start-page: 23 year: 2018 ident: ref36 article-title: DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data publication-title: Microbiome doi: 10.1186/s40168-018-0401-z – volume: 33 start-page: e5006 year: 2024 ident: ref56 article-title: AMPActiPred: a three-stage framework for predicting antibacterial peptides and activity levels with deep forest publication-title: Protein Sci doi: 10.1002/pro.5006 – volume: 10 start-page: 1239 year: 2022 ident: ref5 article-title: Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic Bacteria publication-title: Microorganisms doi: 10.3390/microorganisms10061239 – volume: 399 start-page: 629 year: 2022 ident: ref38 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 – volume: 60 start-page: 106684 year: 2022 ident: ref43 article-title: Machine learning in predicting antimicrobial resistance: a systematic review and meta-analysis publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2022.106684 – volume: 10 start-page: 539 year: 2019 ident: ref57 article-title: Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review publication-title: Front Microbiol doi: 10.3389/fmicb.2019.00539 – volume: 447 start-page: 345 year: 2013 ident: ref41 article-title: Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review publication-title: Sci Total Environ doi: 10.1016/j.scitotenv.2013.01.032 – volume: 84 start-page: 523 year: 2010 ident: ref23 article-title: Software survey: VOSviewer, a computer program for bibliometric mapping publication-title: Scientometrics doi: 10.1007/s11192-009-0146-3 – volume: 57 start-page: 359 year: 2006 ident: ref24 article-title: CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature publication-title: J Am Soc inf Sci Tec doi: 10.1002/asi.20317 – volume: 28 start-page: 103410 year: 2023 ident: ref31 article-title: AI in drug discovery: a wake-up call publication-title: Drug Discov Today doi: 10.1016/j.drudis.2022.103410 – volume: 261 start-page: 129848 year: 2024 ident: ref50 article-title: Isolation, characterization, and multimodal evaluation of novel glycolipid biosurfactant derived from Bacillus species: a promising Staphylococcus aureus tyrosyl-tRNA synthetase inhibitor through molecular docking and MD simulations publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2024.129848 – volume: 11 start-page: 842 year: 2020 ident: ref22 article-title: Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019) publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00842 – volume: 181 start-page: 475 year: 2020 ident: ref26 article-title: A deep learning approach to antibiotic discovery publication-title: Cell doi: 10.1016/j.cell.2020.04.001 – volume: 25 start-page: 1315 year: 2021 ident: ref49 article-title: Artificial intelligence to deep learning: machine intelligence approach for drug discovery publication-title: Mol Divers doi: 10.1007/s11030-021-10217-3 – volume: 8 start-page: 34 year: 2019 ident: ref7 article-title: Implementation of antibiotic stewardship in different settings – results of an international survey publication-title: Antimicrob Resist Infect Control doi: 10.1186/s13756-019-0493-7 – volume: 85 start-page: 517 year: 2019 ident: ref18 article-title: Engineering applications of artificial intelligence: a bibliometric analysis of 30 years (1988–2018) publication-title: Eng Appl Artif Intell doi: 10.1016/j.engappai.2019.06.010 – volume: 4 start-page: 189 year: 2022 ident: ref30 article-title: Dual use of artificial intelligence-powered drug discovery publication-title: Nat Mach Intell doi: 10.1038/s42256-022-00465-9 – volume: 320 start-page: 100 year: 2008 ident: ref1 article-title: Bacteria subsisting on antibiotics publication-title: Science doi: 10.1126/science.1155157 – volume: 65 start-page: 365 year: 2020 ident: ref14 article-title: Artificial intelligence: how is it changing medical sciences and its future? publication-title: Indian J Dermatol doi: 10.4103/ijd.IJD_421_20 – volume: 61 start-page: 85 year: 2015 ident: ref45 article-title: Deep learning in neural networks: An overview publication-title: Neural Netw doi: 10.1016/j.neunet.2014.09.003 – volume: 596 start-page: 583 year: 2021 ident: ref25 article-title: Highly accurate protein structure prediction with AlphaFold publication-title: Nature doi: 10.1038/s41586-021-03819-2 – volume: 379 start-page: 109862 year: 2022 ident: ref54 article-title: Incidence, evaluation of detection and identification methods, and antimicrobial resistance of Aeromonas spp. in ready-to-eat foods publication-title: Int J Food Microbiol doi: 10.1016/j.ijfoodmicro.2022.109862 – volume: 28 start-page: 103491 year: 2023 ident: ref12 article-title: Artificial intelligence as a smart approach to develop antimicrobial drug molecules: a paradigm to combat drug-resistant infections publication-title: Drug Discov Today doi: 10.1016/j.drudis.2023.103491 – volume: 35 start-page: e0017921 year: 2022 ident: ref42 article-title: Machine learning for antimicrobial resistance prediction: current practice, limitations, and clinical perspective publication-title: Clin Microbiol Rev doi: 10.1128/cmr.00179-21 |
SSID | ssj0001325413 |
Score | 2.285861 |
SecondaryResourceType | review_article |
Snippet | To systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR) research... ObjectiveTo systematically map the knowledge landscape and development trends in artificial intelligence (AI) applications for antimicrobial resistance (AMR)... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1492709 |
SubjectTerms | antibiotics antimicrobial resistance artificial intelligence bibliometric analysis deep learning Medicine |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQB8QFFcpHaItciRNShBPbG5tbi0Co0vZUJG6WvwKR2oDYwP_gH3fGDqssQuqlt1Xs3Th-s5k39swzIcfaMe-UsiltsBTShVK1tS7B9Xnwf61qAhYKz3_Orq7Fjxt5MznqC3PCsjxwnrjTqLmT1mvRBCscBAuVd1Eo52q4iVZJ5xN83iSYSqsrHAKfiudtTIjCNMAUURi0lvBu0HWDCYgTR5T0-t8jmW9zJSfO5_ID2RpZI_2WR7tN1mK_Qzbm4774R_Iyt6izcEuXS2Q01fBidtOCwieKdcB4HhEdUhIs7XqKz571I2g3EeakQGPhK0P3p0siTdAMITnSTGg8o65zv7FkH5X90y8_dwsszMzlnHAli5zskuvLi1_nV-V42ELpRaWGMjgRmXDRoiJ8Y1ndRsDLOvByEl4Crfbg6GW0rPLQYaZnLXOcz1gbWB20FHyPrPf3fTwg1HrZ8CpIHUMU0FmzIH1oo7OSi7qRBTl5nXnzkDU1DMQiCJNBmAzCZEaYCvIdsVl2RDnsdAGMxIxGYv5lJAX5-oqsgb8P7onYPt4_LQyvgIJBjKxYQfYz0stbIXeTQKgLolZsYGUsqy19d5ckurGcF8nZ4f8Y_SeyiTOSF34-k_Xh8Sl-ASo0uKNk9X8BDfQMUg priority: 102 providerName: Directory of Open Access Journals |
Title | Mapping knowledge landscapes and emerging trends in artificial intelligence for antimicrobial resistance: bibliometric and visualization analysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39935800 https://www.proquest.com/docview/3165854980 https://pubmed.ncbi.nlm.nih.gov/PMC11810743 https://doaj.org/article/e93b5ac947da4b2491cbe48bb20cb983 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA7LCuKLeLe6LhF8EippLm0iLIuKyyKMTw7MW8ita2G3ozNd0Z_hP95z0s6wI_Pi27RJ25l-J3O-k-R8h5A3xrPgtXZ522AplY-lbrkpwfUF8H-tbiImCs--1udz-WWhFgdkU95qeoHrvaEd1pOary7f_f755xQG_AlGnOBvAYGEmp9cwbA3vMF0vjvgmBosaDCb2H6echEQDeWCyZybutRKL8Z1zv132fFUWdB_Hwv9dzPlLe909oDcn2gl_TDawUNykPpH5O5sWjh_TP7OHAoxXNDtHBrNSb64_WlN4RPFRGEsWESHvEuWdj1FqxoFJmh3S7mTAs-FS4buqssqTtAMMTvyUGh8T33nLzGnH6X_851_dWvM3BzzPeHMqILyhMzPPn_7dF5O1RjKICs9lNHLxKRPDiXjG8d4mwBQ58ENKviXaE0AJqCSY1WADrWpW-aFqFkbGY9GSfGUHPbLPj0n1AXViCoqk2KS0NmwqEJsk3dKSN6ogrzdvHn7YxTdsBCsIEwWYbIIk51gKshHxGbbEfWy84nl6sJOw88mI7xywcgmOukh5KyCT1J7z8FUjRYFeb1B1sL4wkUT16fl9dqKCjgaBNGaFeTZiPT2UUjuFDDugugdG9j5Lrstffc9a3hjvi-ytxf_81Nfknt4OM4AHZHDYXWdXgEnGvxxnks4zvZ-A7EEDaE |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mapping+knowledge+landscapes+and+emerging+trends+in+artificial+intelligence+for+antimicrobial+resistance%3A+bibliometric+and+visualization+analysis&rft.jtitle=Frontiers+in+medicine&rft.au=Wang%2C+Zhongli&rft.au=Zhu%2C+Gaopei&rft.au=Li%2C+Shixue&rft.date=2025&rft.issn=2296-858X&rft.eissn=2296-858X&rft.volume=12&rft_id=info:doi/10.3389%2Ffmed.2025.1492709&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fmed_2025_1492709 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-858X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-858X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-858X&client=summon |